Lipid homeostasis, lipotoxicity and the metabolic syndrome

Biochimica Et Biophysica Acta
Roger H UngerLelio Orci

Abstract

In the 20th century industrialized nations have become afflicted with an unprecedented pandemic of increased adiposity. In the United States, the epicenter of the epidemic, over 2/3 of the population, is overweight and 1 of every 6 Americans carries the diagnosis of metabolic syndrome. Although genes determine susceptibility to environmental factors, the epidemic is clearly due to increased consumption of calorie-dense, highly lipogenic foods, coupled with a marked decrease in physical exertion resulting from modern technologies. If this lifestyle continues, morbid consequences are virtually inevitable. They include type II diabetes and a cluster of disorders known as "the metabolic syndrome" usually appearing in middle age. The morbid consequences of the chronic caloric surplus are buffered before middle age by the partitioning of these calories as fat in the adipocyte compartment which is specifically designed to store triglycerides. Leptin has been proposed as the major hormonal regulator of the partitioning of surplus calories. However, multiple factors can determine the storage capacity of the fat tissue and when it is exceeded ectopic lipid deposition begins. The organs affected in metabolic syndrome include skeletal musc...Continue Reading

References

Jul 1, 1977·The Journal of Clinical Investigation·J D McGarryD W Foster
Aug 1, 1992·The Journal of Clinical Investigation·A OgawaR H Unger
Nov 10, 1995·The Journal of Biological Chemistry·P E SchererH F Lodish
Jul 28, 1995·Science·M A PelleymounterF Collins
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·G ChenR H Unger
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·M ShimabukuroR H Unger
Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y T ZhouR H Unger
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·M HigaR H Unger
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·Y T ZhouR H Unger
Feb 7, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R H Unger, L Orci
Apr 4, 2001·The Journal of Clinical Investigation·H C ChiuJ E Schaffer
Jan 16, 2002·JAMA : the Journal of the American Medical Association·Earl S FordWilliam H Dietz
Feb 22, 2002·The New England Journal of Medicine·Elif Arioglu OralAbhimanyu Garg
Jun 27, 2003·Trends in Endocrinology and Metabolism : TEM·Anil K Agarwal, Abhimanyu Garg
Oct 22, 2003·Obesity Research·Lorraine Lanningham-FosterJames A Levine
Feb 11, 2004·Proceedings of the National Academy of Sciences of the United States of America·Lelio OrciRoger H Unger
Sep 2, 2004·American Journal of Physiology. Endocrinology and Metabolism·Lidia S SzczepaniakRobert L Dobbins
Feb 11, 2005·American Journal of Physiology. Endocrinology and Metabolism·Priya PillutlaIra J Goldberg
Mar 29, 2005·Diabetes·Nicola AbateViswanathan Mohan
Apr 6, 2006·Annals of Internal Medicine·Jonathan M McGavockUNKNOWN American College of Physicians and the American Physiological Society
Jan 19, 2007·The New England Journal of Medicine·I Sadaf FarooqiStephen O'Rahilly
Mar 22, 2007·American Journal of Physiology. Endocrinology and Metabolism·Angela C SmithDavid J Dyck
May 22, 2007·Metabolism: Clinical and Experimental·Michael A KirályMichael C Riddell
Aug 25, 2007·The Journal of Clinical Investigation·Ja-Young KimPhilipp E Scherer

❮ Previous
Next ❯

Citations

May 15, 2010·Herz·Dirk Müller-WielandJörg Kotzka
Sep 5, 2012·Heart Failure Reviews·Kiterie M E FallerJürgen E Schneider
Sep 8, 2012·The Proceedings of the Nutrition Society·Lynda M Williams
Apr 3, 2012·Public Health Nutrition·Bernt J von ScholtenTine Jess
Jul 25, 2012·Cell Death & Disease·K P TamilarasanG Hoefler
Oct 12, 2010·Médecine sciences : M/S·Camille VatierCorinne Vigouroux
Mar 28, 2012·Proceedings of the National Academy of Sciences of the United States of America·Kai SunPhilipp E Scherer
Aug 29, 2013·Journal of Toxicology and Environmental Health. Part a·Sarah L GrayHing Man Chan
May 22, 2010·Current Opinion in Nephrology and Hypertension·Ion Alexandru Bobulescu
May 12, 2011·American Journal of Physiology. Endocrinology and Metabolism·Katsuhiko Funai, Clay F Semenkovich
Oct 19, 2010·Journal of Obesity·Barry Sears, Camillo Ricordi
Apr 14, 2012·Circulation Research·Luigi FontanaValter D Longo
Jun 3, 2011·The Journal of Clinical Investigation·Kai SunPhilipp E Scherer
Mar 19, 2011·Journal of Lipid Research·Raul A BastarracheaElizabeth J Parks
Mar 7, 2012·The Journal of Clinical Endocrinology and Metabolism·Nicola Abate
Dec 21, 2011·Disease Models & Mechanisms·Yaniv ShpilbergMichael C Riddell
Mar 17, 2012·Disease Models & Mechanisms·Kerstin StemmerPaul T Pfluger
Apr 3, 2012·Journal of Cell Science·Ilias MylonisGeorge Simos
Oct 11, 2012·PloS One·Mi-Kyung ShinVsevolod Y Polotsky
Jul 23, 2013·PloS One·Amanda E CrunkJames L McManaman
Apr 30, 2015·Journal of Diabetes Research·Isabel Moreno-Indias, Francisco José Tinahones
Oct 22, 2013·Diabetes & Metabolism·M Lafontan
Apr 9, 2013·Indian Journal of Endocrinology and Metabolism·Gilberto Paz-FilhoJulio Licinio
Jan 15, 2014·Best Practice & Research. Clinical Endocrinology & Metabolism·Caroline TaoWilliam L Holland
Mar 20, 2013·Mediators of Inflammation·Débora EstadellaAline de Piano
Aug 6, 2014·Obesity Research & Clinical Practice·Hiroshi YatsuyaKoji Tamakoshi
Jul 21, 2011·Journal of Lipids·You-Guo Niu, Rhys D Evans
May 30, 2014·Nutrition Research Reviews·Gema FrühbeckAmaia Rodríguez
Oct 30, 2014·Diabetologia·Christoph Heier, Robert Zimmermann
Feb 14, 2013·Journal of Lipid Research·James L McManamanAndrew S Greenberg
Feb 16, 2013·The Journal of Biological Chemistry·Kathrin A ZierlerGuenter Haemmerle
Mar 12, 2013·Endocrine Reviews·Hyun-Seuk MoonChristos S Mantzoros

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Annual Review of Medicine
Roger H Unger
Apoptosis : an International Journal on Programmed Cell Death
Christine M KusminskiPhilipp E Scherer
Annual Review of Physiology
Roger H Unger
© 2022 Meta ULC. All rights reserved